Mammaglobin-based strategies for treatment of breast cancer

Keyphrases

• Breast Cancer Treatment 100%
• Mammaglobin 100%
• Breast Cancer Cells 41%
• Breast 16%
• Normal Breast Epithelium 16%
• In Vitro Study 8%
• Tumor Cells 8%
• Breast Tumor Cells 8%
• Antigen-presenting Cells 8%
• Binding Specificity 8%
• Genetic Ablation 8%
• Induced Apoptosis 8%
• Nonmalignant 8%
• Human Breast Cancer 8%
• Promoter Region 8%
• Tissue Specificity 8%
• Gene Family 8%
• MHC Molecules 8%
• Tumor Antigen 8%
• Radioisotopes 8%
• Promising Target 8%
• T Cell Immune Response 8%
• Breast Epithelium 8%
• Derived Peptide 8%
• Stromal Component 8%
• Apoptosis Inducers 8%
• Bax Gene 8%
• Targeted Killing 8%
• Secretoglobin 8%

Immunology and Microbiology

• Cancer Cell 100%
• Breast Epithelium 60%
• Tumor Cell 40%
• Programmed Cell Death 40%
• Adipose Tissue 20%
• T Cell 20%
• Promoter Region 20%
• Antigen-Presenting Cell 20%
• Adoptive Immunity 20%
• Multigene Family 20%
• Tissue Specificity 20%
• Peptides 20%
• In Vitro 20%

Biochemistry, Genetics and Molecular Biology

• Mammaglobin 100%
• Cancer Cell 41%
• Programmed Cell Death 16%
• T Cell 8%
• In Vitro Study 8%
• Promoter Region 8%
• Multigene Family 8%
• Genetic Ablation 8%
• Antigen Presenting Cell 8%
• Tissue Specificity 8%
• Cellular Immunity 8%
• Secretoglobin 8%